Constitutively Active Akt Induces Ectodermal Defects and Impaired Bone Morphogenetic Protein Signaling
Overview
Molecular Biology
Authors
Affiliations
Aberrant activation of the Akt pathway has been implicated in several human pathologies including cancer. However, current knowledge on the involvement of Akt signaling in development is limited. Previous data have suggested that Akt-mediated signaling may be an essential mediator of epidermal homeostasis through cell autonomous and noncell autonomous mechanisms. Here we report the developmental consequences of deregulated Akt activity in the basal layer of stratified epithelia, mediated by the expression of a constitutively active Akt1 (myrAkt) in transgenic mice. Contrary to mice overexpressing wild-type Akt1 (Akt(wt)), these myrAkt mice display, in a dose-dependent manner, altered development of ectodermally derived organs such as hair, teeth, nails, and epidermal glands. To identify the possible molecular mechanisms underlying these alterations, gene profiling approaches were used. We demonstrate that constitutive Akt activity disturbs the bone morphogenetic protein-dependent signaling pathway. In addition, these mice also display alterations in adult epidermal stem cells. Collectively, we show that epithelial tissue development and homeostasis is dependent on proper regulation of Akt expression and activity.
Marechal E, Poliard A, Henry K, Moreno M, Legrix M, Macagno N Front Cell Dev Biol. 2022; 10:1013001.
PMID: 36353506 PMC: 9637999. DOI: 10.3389/fcell.2022.1013001.
Hypertrichotic patches as a mosaic manifestation of Proteus syndrome.
Pithadia D, Roman J, Sapp J, Biesecker L, Darling T J Am Acad Dermatol. 2020; 84(2):415-424.
PMID: 32035943 PMC: 7415737. DOI: 10.1016/j.jaad.2020.01.078.
Monti P, Ciribilli Y, Foggetti G, Menichini P, Bisio A, Cappato S Biosci Rep. 2019; 39(12).
PMID: 31789342 PMC: 6914664. DOI: 10.1042/BSR20192114.
A mouse model of Proteus syndrome.
Lindhurst M, Brinster L, Kondolf H, Shwetar J, Yourick M, Shiferaw H Hum Mol Genet. 2019; 28(17):2920-2936.
PMID: 31194862 PMC: 6736390. DOI: 10.1093/hmg/ddz116.
PI3K/AKT pathway regulates E-cadherin and Desmoglein 2 in aggressive prostate cancer.
Barber A, Castillo-Martin M, Bonal D, Jia A, Rybicki B, Christiano A Cancer Med. 2015; 4(8):1258-71.
PMID: 26033689 PMC: 4559037. DOI: 10.1002/cam4.463.